Search clinical trials for: tamoxifen

Total 471 results

European Organisation for Research and Treatment...

Completed

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

France, Thailand, Australia, Belgium, Netherlands, Slovenia, United Kingdom, Malaysia, Poland, Russian Federation, Philippines, Taiwan
AstraZeneca

Completed

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Breast Cancer | Metastasis

United States, Australia, Brazil, France, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Poland, Japan, Argentina, Austria, Canada, Hungary, Israel, Netherlands, New Zealand, Portugal, Taiwan, Germany, Finlan... and more
AstraZeneca

Completed

ATAC - Arimidex, Tamoxifen Alone or in Combination

Breast Cancer
Northwestern University
National Cancer Institute (NCI)

Withdrawn

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Breast Cancer

United States
National University Hospital, Singapore

Completed

Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer

Breast Cancer

Singapore
Pfizer

Completed

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy (TAMARA)

Breast Neoplasms

Turkey
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia... and other collaborators

Completed

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

Breast Cancer

United States
Pfizer

Completed

Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer (TEAM)

Breast Neoplasms

France
King Faisal Specialist Hospital & Research Center

Unknown

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Breast Cancer
Pfizer

Completed

Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects

Pharmacokinetics

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Tata Memorial Hospital
Indian Council of Medical Research

Unknown

Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients (CONSET)

Breast Cancer | Pulmonary Fibrosis

India
Zhejiang Cancer Hospital

Completed

Zoladex Plus Tamoxifen in Breast Cancer

Ultrasonography | Lipemia | Endometrium | Mammography | Estrogen

China
Taiho Pharmaceutical Co., Ltd.

Completed

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Breast Cancer

Japan
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Breast Cancer

United States, Canada, Puerto Rico
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)
NYU Langone Health
National Cancer Institute (NCI)

Completed

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Breast Cancer

United States
Georgetown University
National Cancer Institute (NCI)

Completed

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer

Breast Cancer
Northwestern University
National Cancer Institute (NCI)

Completed

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

Breast Cancer | Osteoporosis

United States
AstraZeneca

Completed

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

Prostate Cancer

Italy
AstraZeneca

Completed

Casodex - Nolvadex Combination

Prostate Cancer | Gynaecomastia
AstraZeneca

Completed

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients (SOSTA)

Breast Cancer
Technical University of Munich

Unknown

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Breast Cancer

Germany
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Ovarian Cancer

United States
Yonsei University
Inje University

Completed

Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

Breast Neoplasms | Antineoplastic Agents | Therapeutic Uses | Survival Analysis

Korea, Republic of
Pfizer

Completed

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) (FAST)

Post Menopausal Women With Early Breast Cancer
AGO Study Group

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube

Germany
Malaysia Palm Oil Board

Completed

A Pilot Clinical Trial With Tocotrienol on Breast Cancer (BC)

Breast Cancer

Malaysia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Breast Cancer

United States
AstraZeneca

Completed

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (TIME 2 CHANGE)

Breast Cancer | Post Menopausal

Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Breast Cancer

United States
Bader, Ted, M.D.

Completed

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

Chronic Hepatitis C

United States
Pfizer

Completed

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Breast Neoplasms

Belgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
National Cancer Center, Korea

Terminated

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Breast Cancer | Metastatic Disease

Korea, Republic of
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Breast Cancer

United States, Canada
AstraZeneca

Completed

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Breast Cancer

United States, Brazil, Czech Republic, France, Hungary, Japan, Belgium, Canada, Netherlands, Italy
Medco Health Solutions, Inc.
Mayo Clinic; International Business Machines (IBM); Laboratory Corporation of... and other collaborators

Completed

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer (MHSLabCorp1)

Breast Neoplasms | Tamoxifen

United States
Korea University Anam Hospital
National Cancer Center, Korea; Korean Breast Cancer Study Group

Unknown

CYP2D6 Genotype on the Clinical Effect of Tamoxifen (ASTRRA-CYP2D6)

Breast Neoplasms | Genotype | Tamoxifen | CYP2D6

Korea, Republic of
Yale University

Completed

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI); Norris Cotton Cancer Center

Completed

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Breast Cancer

United States
Korean Breast Cancer Study Group

Unknown

Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women (ASTRRA)

Breast Cancer

Korea, Republic of
Institut Claudius Regaud
PHARMACIA SAS

Completed

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant (TAMARO)

Breast Neoplasms

France
AstraZeneca
German Adjuvant Breast Cancer Group

Completed

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. (ARNO-95)

Breast Cancer

Germany
AstraZeneca

Completed

ATAC - Pharmacokinetics (PK) Sub-Protocol

Breast Cancer
AstraZeneca
Institute of Cancer Research, United Kingdom

Completed

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Breast Cancer

Italy
AstraZeneca

Completed

ATAC - Quality of Life Sub-Protocol

Quality of Life
AstraZeneca

Completed

ATAC - Endometrial Sub-Protocol

Breast Cancer
AstraZeneca

Completed

ATAC - Bone Density Sub-Protocol

Bone Density
Institute of Cancer Research, United Kingdom

Unknown

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Cancer

United Kingdom, Belgium

3

Subscribe